ICTR Focus March 2017 Newsletter                                                       

In This Issue

  • Multi-Center Trial Resources in New CTSA Network
  • Upcoming: Investigator Training Program 
  • Repurposing of Existing Drugs
  • New funding opportunities 
    CTSA Trial Innovation Network 

    The Trial Innovation Network is a new resource for investigators to request services and consultations for multi-center clinical trials and studies. This network is an NIH initiative composed of CTSA Hubs across the United States, Trial Innovation Centers, and the Recruitment Innovation Center. Features of the network include:

    • a single IRB system;
    • quality by design approaches;
    • master contracting agreements;
    • strategies for patient recruitment

    Each CTSA Hub has its own Trial Innovation Network Team to streamline the process of using the network. Drs. Marla Keller and Barrett Katz serve as Team Faculty Directors for Einstein-Montefiore. To learn more, click here. 
    Clinical Research Process Initiative
    An executive team is now hosting a bi-campus, monthly, Research Strategy Forum for departmental leadership in order to get input from our community and investigators as new research tools, policies, and processes are put into place. The team includes the Directors of Epic, Montefiore Research Administration, Clinical Research Informatics, the Office of Clinical Trials, and Einstein Administration. The first Forum presentation focused on Epic and Velos research IT processes, and you can see the PowerPoint here. All future presentations will also be archived for you to review.
    Investigator Training Program
    Save the date for the upcoming program, An Investigator Training Program: A course outlining industry sponsored clinical trial processes from planning to closeout. This event is presented by the Office of Clinical Trials and will take place on April 5th and 6th in Tishman Hall at the Moses Campus. The two-day symposium will provide practical recommendations for activating, conducting and completing an industry sponsored clinical trial successfully and efficiently. Clinical Trialists, Investigators and their research teams are invited to register in March. For more information, click here.  
    New Funding: Repurposing of Existing Drugs

    The National Center for Advancing Translational Science (NCATS) is collaborating with AstraZeneca and Janssen Research & Development, LLC in seeking applications through its NIH-Industry Partnerships initiative to find new treatments for patients by using experimental drug or biologics. This initiative is a part of NCATS' Discovering New Therapeutic Uses for Existing Molecules program and plans to commit $6 million to fund six to ten awards. Applications are due April 17th, 2017. For more information, click here. 
    NIH Clinical Trial Funding Opportunity Announcement Policy Update

    Effective on January 25th, 2018, all grant applications with plans to conduct clinical trials must be submitted in response to a Funding Opportunity Announcement which specifically states that clinical trials are allowed. Applications planning a clinical trial that are submitted to a non-clinical trial FOA will not be reviewed after that date. For a list of planning guidelines until 2018 and to learn more, click here. 
    Subject Reimbursement System Information Session
    The next Lunch & Learn:  Greenphire Clincard Subject Reimbursement System  featuring   Edith Brown , Project Manager, OCT will take place on March 30th, 2017 from 12-1pm in Moses Research Tower, 4th Floor, Clinical Research Center Conference Room. To learn more and RSVP, click here
    Funding Opportunities 

    Contact the Office of Grant Support for personalized search opportunities here. 
    Research in the Headlines 
    Harold and Muriel Block Institute for Clinical and Translational Research